PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES OF LCZ696, A NOVEL DUAL-ACTING ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR (ARNI)

被引：0
|
作者：
Gu, J.
Noe, A.
Chandra, R.
Al-Fayoumi, S.
Ligueros, M. [1 ]
Sarangapani, R. [1 ]
Maahs, S.
Ksander, G.
Rigel, D.
Jeng, A.
Dole, W.
机构：
[1] Novartis Pharmaceut, E Hanover, NJ USA
来源：
JOURNAL OF HYPERTENSION | 2009年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S9 / S9
页数：1
相关论文
共 50 条
  • [31] The angiotensin II receptor-neprilysin inhibitor LCZ696 attenuates the progression of proteinuria in type 2 diabetic rats
    Rahman, Asadur
    Sherajee, Shamshad J.
    Rafiq, Kazi
    Kobara, Hideki
    Masaki, Tsutomu
    Nakano, Daisuke
    Morikawa, Takashi
    Konishi, Yoshio
    Imanishi, Masahito
    Nishiyama, Akira
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2020, 142 (03) : 124 - 126
  • [32] Dual-Acting Angiotensin Receptor-Neprilysin Inhibition
    Segura, Julian
    Ruilope, Luis M.
    CURRENT HYPERTENSION REPORTS, 2011, 13 (01) : 74 - 78
  • [33] Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor (vol 56, pg 1461, 2017)
    Ayalasomayajula, Surya
    Langenickel, Thomas
    Pal, Parasar
    Boggarapu, Sreedevi
    Sunkara, Gangadhar
    CLINICAL PHARMACOKINETICS, 2018, 57 (01) : 105 - 123
  • [34] Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients
    Desai, Akshay S.
    McMurray, John J. V.
    Packer, Milton
    Swedberg, Karl
    Rouleau, Jean L.
    Chen, Fabian
    Gong, Jianjian
    Rizkala, Adel R.
    Brahimi, Abdel
    Claggett, Brian
    Finn, Peter V.
    Hartley, Loren Howard
    Liu, Jiankang
    Lefkowitz, Martin
    Shi, Victor
    Zile, Michael R.
    Solomon, Scott D.
    EUROPEAN HEART JOURNAL, 2015, 36 (30) : 1990 - 1997
  • [35] Angiotensin II Receptor-Neprilysin Inhibitor, LCZ696 Blocked Aldosterone Synthesis in Human Adrenocortical Cell Line
    Miura, S.
    Suematsu, Y.
    Matsuo, Y.
    Tomita, S.
    Nakayama, A.
    Goto, M.
    Yahiro, E.
    Uehara, Y.
    Saku, K.
    EUROPEAN HEART JOURNAL, 2015, 36 : 662 - 662
  • [36] Effect of food on the oral bioavailability of the angiotensin receptor-neprilysin inhibitor sacubitril/valsartan (LCZ696) in healthy subjects
    Ayalasomayajula, Surya
    Langenickel, Thomas H.
    Chandra, Priya
    Wolfson, Edward D.
    Albrecht, Diego
    Zhou, Wel
    Pal, Parasar
    Rajman, Iris
    Sunkara, Gangadhar
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2016, 54 (12) : 1012 - 1018
  • [37] Pre-treatment with LCZ696, an orally active angiotensin receptor neprilysin inhibitor, prevents ischemic brain damage
    Bai, Hui-Yu
    Mogi, Masaki
    Nakaoka, Hirotomo
    Kan-no, Harumi
    Tsukuda, Kana
    Chisaka, Toshiyuki
    Wang, Xiao-Li
    Kukida, Masayoshi
    Shan, Bao-Shuai
    Yamauchi, Toshifumi
    Higaki, Akinori
    Iwanami, Jun
    Horiuchi, Masatsugu
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 762 : 293 - 298
  • [38] Effect of the angiotensin receptor neprilysin inhibitor LCZ696 compared with enalapril according to baseline risk in PARADIGM-HF
    Simpson, J.
    Squire, I. B.
    Martinez, F.
    Rouleau, J. L.
    Swedberg, K.
    Zile, M.
    Lefkowitz, M.
    Packer, M.
    Mcmurray, J. J. V.
    Solomon, S. D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 295 - 296
  • [39] Disposition and metabolism of [14C] Sacubitril/Valsartan (formerly LCZ696) an angiotensin receptor neprilysin inhibitor, in healthy subjects
    Flarakos, Jimmy
    Du, Yancy
    Bedman, Timothy
    Al-Share, Qusai
    Jordaan, Pierre
    Chandra, Priya
    Albrecht, Diego
    Wang, Lai
    Gu, Helen
    Einolf, Heidi J.
    Huskey, Su-Er
    Mangold, James B.
    XENOBIOTICA, 2016, 46 (11) : 986 - 1000
  • [40] Pharmacokinetic Drug-Drug Interaction Assessment of LCZ696 (an Angiotensin Receptor Neprilysin Inhibitor) With Omeprazole, Metformin or Levonorgestrel-Ethinyl Estradiol in Healthy Subjects
    Gan, Lu
    Jiang, Xuemin
    Mendonza, Anisha
    Swan, Therese
    Reynolds, Christine
    Nguyen, Joanne
    Pal, Parasar
    Neelakantham, Srikanth
    Dahlke, Marion
    Langenickel, Thomas
    Rajman, Iris
    Akahori, Mizuki
    Zhou, Wei
    Rebello, Sam
    Sunkara, Gangadhar
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2016, 5 (01): : 27 - 39
12345